Jazz Pharmaceuticals plc

Nasdaq:JAZZ

Pharmaceutical Preparations·DUBLIN

Jazz Pharmaceuticals plc is an American global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

CEO

Gala Renee D

CFO

Johnson Philip L

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/24/26	→
10-Q	Q3 2025	9/30/25	11/5/25	→
10-Q	Q2 2025	6/30/25	8/6/25	→
10-Q	Q1 2025	3/31/25	5/7/25	→
10-K/A	FY 2024	12/31/24	4/25/25	→
10-K	FY 2024	12/31/24	2/26/25	→
↓

Earnings Releases (8-K)

32 shown

Filed	Period
2/24/26	Q1 FY2026	→
1/12/26	Q4 FY2026	→
11/5/25	Q4 FY2025	→
8/5/25	Q3 FY2025	→
5/6/25	Q2 FY2025	→
2/25/25	Q1 FY2025	→
↓

News (8-K)

48 shown

Filed	Type	Description
11/17/25	Other	Other Events	→
10/28/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/22/25	Other	Other Events	→
7/25/25	Vote	Submission of Matters to a Vote of Security Holders	→
7/10/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
4/21/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

12 shown

Filed	Form	Description
6/6/25	ARS	ARS	→
6/14/24	ARS	ARS	→
6/16/23	ARS	ARS	→
3/2/22	S-8	S-8	→
5/7/21	S-8	S-8	→
2/23/21	S-8	S-8	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

Mar 9, 2026

0001193210-26-000007PRIMARY DOCUMENT

Mar 5, 2026

4.8 KB

Mar 9, 2026

0002013156-26-000004PRIMARY DOCUMENT

Mar 5, 2026

4.8 KB

Mar 9, 2026

0001989533-26-000011PRIMARY DOCUMENT

Mar 5, 2026

5.3 KB

Mar 9, 2026

0001805688-26-000006PRIMARY DOCUMENT

Mar 5, 2026

4.8 KB

Mar 9, 2026

0001737329-26-000006PRIMARY DOCUMENT

Mar 5, 2026

4.8 KB

Mar 9, 2026

0001784606-26-000012PRIMARY DOCUMENT

Mar 5, 2026

6.6 KB

Mar 9, 2026

0001607737-26-000006PRIMARY DOCUMENT

Mar 5, 2026

4.8 KB

Mar 9, 2026

0001783908-26-000010PRIMARY DOCUMENT

Mar 5, 2026

4.8 KB

144

Mar 9, 2026

0001950047-26-002363

—

8.8 KB

144

Mar 5, 2026

0001784606-26-000010

—

6.2 KB

144

Mar 5, 2026

0001989533-26-000009

—

5.6 KB

Mar 4, 2026

0001193210-26-000005PRIMARY DOCUMENT

Mar 3, 2026

9.0 KB

144

Mar 3, 2026

0001628280-26-013667

—

5.6 KB

Mar 2, 2026

0001161662-26-000002PRIMARY DOCUMENT

Feb 27, 2026

8.8 KB

Mar 2, 2026

0002013156-26-000002PRIMARY DOCUMENT

Feb 26, 2026

5.4 KB

Mar 2, 2026

0001805688-26-000004PRIMARY DOCUMENT

Feb 26, 2026

5.1 KB

Mar 2, 2026

0001737329-26-000004PRIMARY DOCUMENT

Feb 26, 2026

5.1 KB

Mar 2, 2026

0001784606-26-000007PRIMARY DOCUMENT

Feb 26, 2026

8.5 KB

Mar 2, 2026

0001607737-26-000004PRIMARY DOCUMENT

Feb 26, 2026

5.2 KB

Mar 2, 2026

0001188919-26-000002PRIMARY DOCUMENT

Feb 26, 2026

8.8 KB

Mar 2, 2026

0001783908-26-000007PRIMARY DOCUMENT

Feb 26, 2026

39.4 KB

Mar 2, 2026

0001989533-26-000006PRIMARY DOCUMENT

Feb 26, 2026

7.2 KB

144

Feb 27, 2026

0001950047-26-001896

—

7.5 KB

144

Feb 27, 2026

0001950047-26-001882

—

4.9 KB

144

Feb 26, 2026

0001950047-26-001834

—

7.2 KB

25 filings shown

Filed	Form	Description
7/14/25	DEFA14A	DEFA14A	→
7/10/25	DEFA14A	DEFA14A	→
6/6/25	DEFA14A	DEFA14A	→
6/6/25	DEF 14A	DEF 14A	→
5/23/25	PRE 14A	PRE 14A	→
7/22/24	DEFA14A	DEFA14A	→
↓

Jazz Pharmaceuticals plc

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/9/26	4	PRIMARY DOCUMENT	→
3/9/26	4	PRIMARY DOCUMENT	→
3/9/26	4	PRIMARY DOCUMENT	→
3/9/26	4	PRIMARY DOCUMENT	→
3/9/26	4	PRIMARY DOCUMENT	→
3/9/26	4	PRIMARY DOCUMENT	→
↓

Filed	Form	Description
3/9/26	144	144	→
3/5/26	144	144	→
3/5/26	144	144	→
3/3/26	144	144	→
2/27/26	144	144	→
2/27/26	144	144	→
↓